Ian E. Krop, MD, PhD, has been named as Section Chief of Medical Oncology and Hematology and Deputy Director for Clinical Affairs for Yale Cancer Center and Smilow Cancer Hospital. Dr. Krop is an international leader in breast cancer care and clinical investigation. He joined Yale in 2022 and is a physician-leader across Yale School of Medicine and the Yale New Haven Health System. He is widely recognized for his collaborative leadership approach and focus on quality, safety, and innovation in cancer care.
Ian E. Krop, MD, PhD
Dr. Krop has served as Chief Clinical Research Officer and Medical Director of the Clinical Trials Office for Yale Cancer Center for the last 4 years. Under his leadership, the Clinical Trials Office has changed significantly. As Section Chief and Deputy Director, Dr. Krop will provide broad strategic and operational leadership for the medical oncology and hematology program in the Department of Medicine and across Yale Cancer Center and all Smilow Cancer Hospital locations.
As Deputy Director for Clinical Affairs, Dr. Krop will have broad oversight over clinical trials and clinical research. His impact at Yale reflects his longstanding national and international leadership in oncology. Prior to joining Yale, he was at Dana-Farber Cancer Institute for 20 years where he focused on drug development in breast cancer. Nationally, he serves as Chief Scientific Officer for the Translational Breast Cancer Research Consortium.
